Mylan Institutional LLC
NDC labeler codes: 67457, 72078
What is a labeler?
The company whose name is on the package and in the FDA’s National Drug Code (NDC) Directory. It may make the medicine itself or sell medicine made by another company. The first part of every NDC code identifies the labeler.
Official FDA data only
Products, approvals and recalls come from the FDA (NDC Directory, Drugs@FDA, enforcement reports). Recalls are linked to this company by the NDC labeler code on the recalled product.
Questions about your medicine: ask your doctor or pharmacist. In an emergency, call 911.
Prescription medicines
- VancomycinTyzavan, Vancocin · 9 products
- Fondaparinux sodiumArixtra · 8 products
- DocetaxelBeizray, Docivyx · 7 products
- DexamethasoneTaperdex 6-Day, Hemady, Taperdex 12-Day · 7 products
- Remifentanil hydrochlorideUltiva · 6 products
- Eptifibatide6 products
- Adenosine5 products
- LevetiracetamKeppra, Spritam, Keppra XR · 4 products
- Octreotide acetateSandostatin, Bynfezia Pen · 3 products
- Calcitonin salmonMiacalcin · 3 products
- Ferric carboxymaltoseInjectafer · 3 products
- Esmolol hydrochlorideBrevibloc, Esmolol Hydrochloride in Water · 3 products
- Leucovorin calciumVykoura · 3 products
- Triamcinolone acetonideKenalog-40, Triderm, Triesence · 3 products
- Zoledronic acidReclast · 3 products
- Naloxone hydrochlorideNarcan, Rextovy, Zimhi · 3 products
- Isosulfan blue3 products
- DexmedetomidinePrecedex, Dexmedetomidine in Dextrose, Igalmi · 3 products
- GemcitabineAvgemsi, Inlexzo · 3 products
- GranisetronGranisol, Sancuso, Sustol · 3 products
- FamotidinePepcid · 3 products
- Iron sucroseVenofer · 3 products
- Tetradecyl hydrogen sulfate (ester)Sotradecol · 2 products
- DaptomycinDapzura Rt · 2 products
- Amiodarone hydrochloridePacerone, Nexterone · 2 products
- Sodium nitroprussideNipride Rtu · 2 products
- EtomidateAmidate · 2 products
- TobramycinTobramycin Inhalation Solution Pak, Tobi, Tobi Podhaler · 2 products
- EpoprostenolVeletri · 2 products
- SugammadexBridion · 2 products
- Oxaliplatin2 products
- Pamidronate disodium2 products
- Haloperidol decanoate2 products
- Vecuronium bromide2 products
- Acetazolamide2 products
- Ropivacaine hydrochlorideNaropin · 2 products
- Dimethyl sulfoxideRimso-50 · 1 product
- Methadone hydrochlorideMethadone Hydrocloride Dye-Free, Sugar-Free, Unflavored, Methadose, Methadose Sugar-Free · 1 product
- FosaprepitantFocinvez, Emend, Navitrux · 1 product
- Cidofovir dihydrate1 product
Show the other 26 medicines
- Rifampin1 product
- Bivalirudin1 product
- Fluphenazine decanoate1 product
- DoxycyclineDoxy 100, Acticlate Cap, Doryx Mpc · 1 product
- ProchlorperazineCompro · 1 product
- TrastuzumabOgivri, Kanjinti, Herzuma · 1 product
- Meropenem1 product
- Fomepizole1 product
- Mycophenolate mofetilCellcept, Myhibbin · 1 product
- ClonidineClonidine Transdermal System, Catapres-Tts-1, Clonidine Transdermal System Usp, 0.1 Mg/Day · 1 product
- PosaconazoleNoxafil · 1 product
- Medroxyprogesterone acetateProvera, Depo-Provera, Depo-Subq Provera · 1 product
- Decitabine1 product
- MoxifloxacinVigamox · 1 product
- Doxorubicin hydrochlorideDoxil, Doxorubicin Hydrochloride Liposome · 1 product
- Norepinephrine bitartrateLevophed · 1 product
- Thiamine hydrochloride1 product
- Rocuronium bromide1 product
- Haloperidol1 product
- AllopurinolAloprim · 1 product
- Amphotericin b1 product
- PaclitaxelPaclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound), Paclitaxel 100mg Per Vial, Abraxane · 1 product
- Acetaminophen1 product
- Tranexamic acidCyklokapron · 1 product
- Argatroban1 product
- Palonosetron hydrochloridePosfrea · 1 product
FDA applications for these products
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
- BLA: Biologics License Application: how a biologic medicine (made from living cells) is approved.
| Approved | Application | Medicine | Sponsor |
|---|---|---|---|
| July 28, 2026 | ANDA213915 | Sugammadex SUGAMMADEX SODIUM | Mylan |
| June 25, 2026 | ANDA212572 | Ferric carboxymaltose FERRIC CARBOXYMALTOSE | Mylan Labs Ltd |
| June 25, 2026 | ANDA217076 | Ferric carboxymaltose FERRIC CARBOXYMALTOSE | Mylan |
| June 25, 2026 | ANDA217769 | Ferric carboxymaltose FERRIC CARBOXYMALTOSE | Mylan |
| August 19, 2025 | ANDA217877 | Paclitaxel PACLITAXEL | Mylan |
| August 8, 2025 | ANDA212559 | Iron sucrose IRON SUCROSE | Mylan Labs Ltd |
| June 30, 2025 | ANDA212967 | Amphotericin b AMPHOTERICIN B | Mylan Labs Ltd |
| June 23, 2025 | ANDA219084 | Meropenem MEROPENEM | Brooks Steriscience |
| June 12, 2024 | ANDA213913 | Epoprostenol EPOPROSTENOL SODIUM | Mylan |
| December 26, 2023 | ANDA211500 | Posaconazole POSACONAZOLE | Mylan Labs Ltd |
| October 26, 2023 | ANDA206091 | Ropivacaine hydrochloride ROPIVACAINE HYDROCHLORIDE | Mylan Labs Ltd |
| August 7, 2023 | ANDA213966 | Daptomycin DAPTOMYCIN | Mylan |
| November 2, 2022 | ANDA212567 | Triamcinolone acetonide TRIAMCINOLONE ACETONIDE | Mylan Labs Ltd |
| June 9, 2022 | ANDA213843 | Naloxone hydrochloride NALOXONE HYDROCHLORIDE | Mylan Labs Ltd |
| August 27, 2020 | ANDA212571 | Dexmedetomidine DEXMEDETOMIDINE HYDROCHLORIDE | Mylan Labs Ltd |
| August 7, 2020 | ANDA213255 | Acetaminophen ACETAMINOPHEN | Mylan |
| September 5, 2019 | ANDA204015 | Fosaprepitant FOSAPREPITANT DIMEGLUMINE | Mylan Labs Ltd |
| April 1, 2019 | ANDA208137 | Docetaxel DOCETAXEL | Mylan Labs Ltd |
| October 25, 2018 | ANDA210710 | Prochlorperazine PROCHLORPERAZINE EDISYLATE | Mylan Labs Ltd |
| October 12, 2018 | ANDA210227 | Medroxyprogesterone acetate MEDROXYPROGESTERONE ACETATE | Xiromed |
| October 4, 2018 | ANDA211242 | Norepinephrine bitartrate NOREPINEPHRINE BITARTRATE | Mylan Labs Ltd |
| September 19, 2018 | ANDA206416 | Palonosetron hydrochloride PALONOSETRON HYDROCHLORIDE | Mylan Institutional |
| July 20, 2018 | ANDA203258 | Eptifibatide EPTIFIBATIDE | Mylan Labs Ltd |
| July 10, 2018 | NDA209481 | Vancomycin VANCOMYCIN HYDROCHLORIDE | Mylan Labs Ltd |
| July 6, 2018 | ANDA210848 | Docetaxel DOCETAXEL | Mylan Labs Ltd |
Show the other 61 applications
| Approved | Application | Medicine | Sponsor |
|---|---|---|---|
| July 2, 2018 | ANDA210072 | Docetaxel DOCETAXEL | Mylan Labs Ltd |
| June 8, 2018 | ANDA206608 | Esmolol hydrochloride ESMOLOL HYDROCHLORIDE | Mylan Labs Ltd |
| June 5, 2018 | ANDA205037 | Daptomycin DAPTOMYCIN | Mylan Labs Ltd |
| June 1, 2018 | ANDA202471 | Bivalirudin BIVALIRUDIN | Mylan Institutional |
| April 30, 2018 | ANDA208859 | Docetaxel DOCETAXEL | Mylan Labs Ltd |
| April 17, 2018 | ANDA210763 | Sodium nitroprusside SODIUM NITROPRUSSIDE | Mylan Labs Ltd |
| December 6, 2017 | ANDA205242 | Gemcitabine GEMCITABINE HYDROCHLORIDE | Mylan Labs Ltd |
| December 1, 2017 | BLA761074 | Trastuzumab OGIVRI | Mylan GmbH |
| October 27, 2017 | ANDA205254 | Zoledronic acid ZOLEDRONIC ACID | Mylan Labs Ltd |
| May 31, 2017 | ANDA204607 | Decitabine DECITABINE | Pharmascience Inc |
| May 19, 2017 | ANDA203800 | Leucovorin calcium LEUCOVORIN CALCIUM PRESERVATIVE FREE | Mylan Labs Ltd |
| May 5, 2017 | ANDA205833 | Moxifloxacin MOXIFLOXACIN HYDROCHLORIDE IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER | Mylan Labs Ltd |
| March 31, 2017 | ANDA203859 | Mycophenolate mofetil MYCOPHENOLATE MOFETIL HYDROCHLORIDE | Mylan Labs Ltd |
| February 14, 2017 | ANDA203841 | Zoledronic acid ZOLEDRONIC ACID | Mylan Labs Ltd |
| February 7, 2017 | ANDA201044 | Etomidate ETOMIDATE | Mylan Labs Ltd |
| September 16, 2016 | ANDA203308 | Levetiracetam LEVETIRACETAM | Mylan Labs Ltd |
| June 29, 2016 | ANDA205014 | Naloxone hydrochloride NALOXONE HYDROCHLORIDE | Mylan Institutional |
| August 18, 2014 | ANDA202881 | Dexmedetomidine DEXMEDETOMIDINE HYDROCHLORIDE | Mylan Institutional |
| June 30, 2014 | ANDA202626 | Argatroban ARGATROBAN | Mylan Institutional |
| March 28, 2014 | ANDA090212 | Adenosine ADENOSINE | Mylan Asi |
| March 6, 2014 | ANDA204997 | Naloxone hydrochloride NALOXONE HYDROCHLORIDE | Mylan Institutional |
| March 4, 2013 | ANDA202650 | Zoledronic acid ZOLEDRONIC ACID | Mylan Labs Ltd |
| August 21, 2012 | ANDA091406 | Doxycycline DOXYCYCLINE | Mylan Labs Ltd |
| August 7, 2012 | ANDA091358 | Oxaliplatin OXALIPLATIN | Mylan Labs Ltd |
| June 27, 2012 | ANDA201276 | Cidofovir dihydrate CIDOFOVIR | Mylan Institutional |
| June 25, 2012 | ANDA091623 | Thiamine hydrochloride THIAMINE HYDROCHLORIDE | Mylan Institutional |
| May 9, 2012 | ANDA200880 | Acetazolamide ACETAZOLAMIDE SODIUM | Mylan Asi |
| November 9, 2011 | NDA202543 | Levetiracetam LEVETIRACETAM IN SODIUM CHLORIDE | Hq Spclt Pharma |
| November 3, 2011 | ANDA091657 | Tranexamic acid TRANEXAMIC ACID | Mylan Institutional |
| October 28, 2011 | ANDA200170 | Doxorubicin hydrochloride DOXORUBICIN HYDROCHLORIDE | Mylan Labs Ltd |
| September 19, 2011 | ANDA091554 | Vancomycin VANCOMYCIN HYDROCHLORIDE | Mylan Labs Ltd |
| February 10, 2011 | ANDA079198 | Octreotide acetate OCTREOTIDE ACETATE (PRESERVATIVE FREE) | Mylan Institutional |
| July 20, 2010 | ANDA090874 | Isosulfan blue ISOSULFAN BLUE | Mylan Institutional |
| May 11, 2010 | ANDA090243 | Vecuronium bromide VECURONIUM BROMIDE | Mylan Labs Ltd |
| April 9, 2010 | ANDA091136 | Granisetron GRANISETRON HYDROCHLORIDE | Mylan Asi |
| April 9, 2010 | ANDA091137 | Granisetron GRANISETRON HYDROCHLORIDE | Mylan Asi |
| September 14, 2009 | ANDA078347 | Haloperidol HALOPERIDOL | Mylan Labs Ltd |
| May 13, 2009 | ANDA078686 | Adenosine ADENOSINE | Mylan Labs Ltd |
| December 30, 2008 | ANDA065397 | Vancomycin VANCOMYCIN HYDROCHLORIDE | Mylan Labs Ltd |
| December 30, 2008 | ANDA065432 | Vancomycin VANCOMYCIN HYDROCHLORIDE | Mylan Labs Ltd |
| November 26, 2008 | ANDA079199 | Rocuronium bromide ROCURONIUM BROMIDE | Mylan Institutional |
| October 31, 2008 | ANDA078520 | Pamidronate disodium PAMIDRONATE DISODIUM | Mylan Labs Ltd |
| August 29, 2008 | ANDA040802 | Dexamethasone DEXAMETHASONE SODIUM PHOSPHATE | Mylan Labs Ltd |
| August 29, 2008 | ANDA040803 | Dexamethasone DEXAMETHASONE SODIUM PHOSPHATE | Mylan Labs Ltd |
| June 25, 2008 | ANDA078641 | Famotidine FAMOTIDINE | Mylan Labs Ltd |
| June 25, 2008 | ANDA078642 | Famotidine FAMOTIDINE PRESERVATIVE FREE | Mylan Labs Ltd |
| May 22, 2008 | ANDA065421 | Rifampin RIFAMPIN | Mylan Labs Ltd |
| March 11, 2008 | ANDA065407 | Tobramycin TOBRAMYCIN SULFATE | Mylan Labs Ltd |
| March 3, 2008 | ANDA078639 | Fomepizole FOMEPIZOLE | Mylan Institutional |
| May 2, 2005 | ANDA076474 | Esmolol hydrochloride ESMOLOL HYDROCHLORIDE | Mylan Institutional |
| November 12, 2004 | ANDA040541 | Tetradecyl hydrogen sulfate (ester) SOTRADECOL | Mylan Institutional |
| October 15, 2002 | ANDA076217 | Amiodarone hydrochloride AMIODARONE HYDROCHLORIDE | Mylan Institutional |
| December 7, 2001 | NDA021345 | Fondaparinux sodium ARIXTRA | Mylan Ireland Ltd |
| August 17, 2001 | ANDA075918 | Fluphenazine decanoate FLUPHENAZINE DECANOATE | Mylan Labs Ltd |
| February 28, 2000 | ANDA075440 | Haloperidol decanoate HALOPERIDOL DECANOATE | Mylan Labs Ltd |
| October 2, 1996 | NDA020615 | Clonidine DURACLON | Mylan Institutional |
| July 12, 1996 | NDA020630 | Remifentanil hydrochloride ULTIVA | Mylan Institutional |
| May 17, 1996 | NDA020298 | Allopurinol ALOPRIM | Mylan |
| July 3, 1986 | NDA017808 | Calcitonin salmon MIACALCIN | Mylan Ireland Ltd |
| April 4, 1978 | NDA017788 | Dimethyl sulfoxide RIMSO-50 | Mylan Institutional |
| August 13, 1947 | NDA021624 | Methadone hydrochloride METHADONE HYDROCHLORIDE | Mylan Institutional |
The sponsor is the company that holds the FDA application; it can differ from the labeler.
Recall timeline
2026
-
August 26, 2026 · Class II · Ongoing · D-0830-2026 · Mycophenolate mofetil
Failed Dissolution Specifications
Carton label: Mycophenolate Mofetil for injection, USP, 500 mg/vial, Sterile, 4 Single Dose Vials, Rx only, Manufactured for: Mylan Institutional LLC, Morgantown, WV 26505, Made in India, NDC 67457-386-81. Vial Label: My
-
July 2, 2026 · Class II · Ongoing · D-0734-2026 · Mycophenolate mofetil
Presence of precipitate
Mycophenolate Mofetil for Injection USP, 500 mg/Vial, Single Dose Vial, 4 vials per carton, Rx only, Manufactured for: Mylan Institutional LLC, Morgantown, WV, 26505 USA, Made in India, NDC 67457-386-00 (vial label) & ND
2025
-
October 10, 2025 · Class II · Ongoing · D-0214-2026 · Haloperidol
Labeling: Not Elsewhere Classified:Incorrect RFID tag labels applied to product by repackaging firm.
Haloperidol Lactate Injection, 5 mg/mL, 25 x 1 mL Single-Dose Vials, Sterile, Rx only, For Intramuscular Use Only, Manufactured for: Mylan Institutional LLC, Morgantown, WV 26605. NDC: 67457-426-12 with Safecor Health LL
2022
-
October 7, 2022 · Class I · Terminated · D-0058-2023 · Octreotide acetate
Presence of Particulate Matter: Product complaint for the presence of glass particles in a syringe.
Octreotide Acetate Injection 500 mcg/mL, 10 x 1 mL Single-Dose Unit-of-Use Syringes, For Subcutaneous or Intravenous Use, Rx Only, Manufactured for: Mylan Institutional LLC, Morgantown, WV 26505 U.S.A., Made in Italy, ND
-
April 13, 2022 · Class II · Terminated · D-1091-2022 · Clonidine
cGMP deviations: Temperature abuse
Duraclon (clonidine HCl injection, USP), 1000 mcg/10 mL (100 mcg/mL), 10 mL single-dose vial, Rx only, MFG: Mylan Pharma, NDC 67457-218-10
-
April 7, 2022 · Class II · Terminated · D-0774-2022 · Rifampin
Failed Impurities/Degradation Specifications: High out of specification results obtained for related compound during stability testing.
Rifampin for Injection, USP, 600 mg/vial, One Vial per carton, Rx only, Manufactured for: Mylan Institutional LLC, Morgantown, WV 26505 U.S.A., NDC 67457-445-60
2021
-
May 3, 2021 · Class III · Terminated · D-0601-2021 · Thiamine hydrochloride
Labeling: Incorrect or Missing Lot and/or Exp Date: Cartons with the correct lot number 200906 contain vials labeled with the incorrect lot number 200901.
Thiamine HCl Injection, USP 200 mg/2 mL (100mg/mL), 2 mL vials, packaged in 25 (2 mL multi-dose vial) per carton, Rx only, Manufactured for: Mylan Institutional LLC, Rockford, IL 61103 USA; Manufactured by: Mylan Institu
2020
-
August 17, 2020 · Class I · Terminated · D-1575-2020 · Amiodarone hydrochloride
Labeling: Label Mix-Up; potential for cartons labeled as Tranexamic Acid Injection, USP to contain vials of Amiodarone HCl Injection, USP and cartons labeled as Amiodarone HCl Injection, USP to contain vials of Tranexamic Acid Injection, USP.
Amiodarone Hydrochloride Injection, USP, 450 mg/9 mL (50 mg/mL), 9 mL Single-Dose Vial (NDC 67457-153-99); 10 x 9 mL Single-Dose Vials per carton (NDC 67457-153-09), Rx only, Manufactured by: Mylan Institutional, Galway,
-
August 17, 2020 · Class I · Terminated · D-1576-2020 · Tranexamic acid
Labeling: Label Mix-Up; potential for cartons labeled as Tranexamic Acid Injection, USP to contain vials of Amiodarone HCl Injection, USP and cartons labeled as Amiodarone HCl Injection, USP to contain vials of Tranexamic Acid Injection, USP.
Tranexamic Acid Injection, USP, 1000 mg/10 mL (100 mg/mL), 10 mL Single-Dose Vial (NDC 67457-197-00); 10 x 10 mL Single-Dose Vials per carton (NDC 67457-197-10), Rx only, Manufactured by: Mylan Institutional, Galway, Ire
-
July 7, 2020 · Class I · Terminated · D-1484-2020 · Daptomycin
Presence of Particulate Matter
Daptomycin for Injection, 500 mg/vial, Single-Dose Vial, Rx only, Sterile, Manufactured for: Mylan Institutional, LLC, Rockford, IL 61103 USA, NDC 67457-813-50
Show the 5 older recalls
2020
-
May 5, 2020 · Class II · Terminated · D-1271-2020 · Allopurinol
Discoloration: Out-of-specification results for appearance obtained during routine stability testing at the end of shelf-life for the parameters Appearance and Color of Solution.
Aloprim (allopurinol sodium) for Injection, 500 mg Single-Dose Vial, Rx only, Manufactured for: Mylan Institutional LLC, Rockford, IL 61103 USA. NDC: 67457-187-50
2019
-
October 7, 2019 · Class II · Terminated · D-0139-2020 · Rifampin
Failed Impurities/Degradation Specifications: discoloration due to elevated unknown impurity results which could decrease the effectiveness of the product.
Rifampin for Injection, USP, 600 mg/vial, Rx only, Manufactured for: Mylan Institutional LLC, Rockford, IL 61103; NDC 67457-445-60.
2015
-
February 18, 2015 · Class II · Terminated · D-0421-2015 · Haloperidol decanoate
Lack of Assurance of Sterility; due to leaking vials
Haloperidol Decanoate Injection, 100 mg/mL, For Intra Muscular Use Only, 1 mL single dose vials (NDC 67457-409-00) packaged in cartons of five (NDC 67457-409-13), Rx only, Manufactured in India for: Mylan Institutional L
-
February 18, 2015 · Class II · Terminated · D-0422-2015 · Haloperidol decanoate
Lack of Assurance of Sterility; due to leaking vials
Haloperidol Decanoate Injection, 50 mg/mL, For Intra Muscular Use Only, 1 mL single dose vials (NDC 67457-410-00) packaged in cartons of ten (NDC 67457-410-13), Rx only, Manufactured in India for: Mylan Institutional LLC
2014
-
September 12, 2014 · Class II · Terminated · D-0005-2015 · Amiodarone hydrochloride
Temperature Abuse: One shipment was inadvertantly stored refrigerated rather than the labeled room temperature recommendation at McKesson Medical-Surgical Inc., one of the distributing wholesalers.
Amiodarone HCl Injection, 450 mg/9 mL (50 mg per mL), 9 mL Single-Use Vial, Rx only, Manufactured for Mylan Institutional, LLC, Rockford, IL 61103, NDC 67457-153-09.
What do the recall classes mean?
Class I: The most serious type: there is a reasonable chance that using the product will cause serious health problems or death.
Class II: Using the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Class III: Using the product is not likely to cause health problems (for example a labeling or packaging issue).
Next steps
- Find a pharmacy near youAsk which company made your medicine and whether it is recalled
- Latest FDA drug recallsAll companies, newest first
- All drug companiesA to Z
- All prescription drugs A to ZSearch by generic, brand or Spanish name
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026